JP2022068197A5 - - Google Patents

Download PDF

Info

Publication number
JP2022068197A5
JP2022068197A5 JP2022014178A JP2022014178A JP2022068197A5 JP 2022068197 A5 JP2022068197 A5 JP 2022068197A5 JP 2022014178 A JP2022014178 A JP 2022014178A JP 2022014178 A JP2022014178 A JP 2022014178A JP 2022068197 A5 JP2022068197 A5 JP 2022068197A5
Authority
JP
Japan
Prior art keywords
examples
prepared
same procedure
procedure
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022014178A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022068197A (ja
JP7781660B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2018/022049 external-priority patent/WO2018169880A1/en
Application filed filed Critical
Publication of JP2022068197A publication Critical patent/JP2022068197A/ja
Publication of JP2022068197A5 publication Critical patent/JP2022068197A5/ja
Application granted granted Critical
Publication of JP7781660B2 publication Critical patent/JP7781660B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022014178A 2017-03-13 2022-02-01 デュアルmagl及びfaahインヒビター Active JP7781660B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762470830P 2017-03-13 2017-03-13
US62/470,830 2017-03-13
PCT/US2018/022049 WO2018169880A1 (en) 2017-03-13 2018-03-12 Dual magl and faah inhibitors
JP2019572352A JP7178375B2 (ja) 2017-03-13 2018-03-12 デュアルmagl及びfaahインヒビター

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019572352A Division JP7178375B2 (ja) 2017-03-13 2018-03-12 デュアルmagl及びfaahインヒビター

Publications (3)

Publication Number Publication Date
JP2022068197A JP2022068197A (ja) 2022-05-09
JP2022068197A5 true JP2022068197A5 (https=) 2022-06-30
JP7781660B2 JP7781660B2 (ja) 2025-12-08

Family

ID=63445929

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2019572352A Active JP7178375B2 (ja) 2017-03-13 2018-03-12 デュアルmagl及びfaahインヒビター
JP2022014178A Active JP7781660B2 (ja) 2017-03-13 2022-02-01 デュアルmagl及びfaahインヒビター
JP2022105683A Active JP7440572B2 (ja) 2017-03-13 2022-06-30 デュアルmagl及びfaahインヒビター
JP2024020785A Pending JP2024056887A (ja) 2017-03-13 2024-02-15 デュアルmagl及びfaahインヒビター
JP2025205384A Pending JP2026035720A (ja) 2017-03-13 2025-11-27 デュアルmagl及びfaahインヒビター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019572352A Active JP7178375B2 (ja) 2017-03-13 2018-03-12 デュアルmagl及びfaahインヒビター

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022105683A Active JP7440572B2 (ja) 2017-03-13 2022-06-30 デュアルmagl及びfaahインヒビター
JP2024020785A Pending JP2024056887A (ja) 2017-03-13 2024-02-15 デュアルmagl及びfaahインヒビター
JP2025205384A Pending JP2026035720A (ja) 2017-03-13 2025-11-27 デュアルmagl及びfaahインヒビター

Country Status (31)

Country Link
US (4) US10350205B2 (https=)
EP (3) EP4335848A3 (https=)
JP (5) JP7178375B2 (https=)
KR (3) KR102613364B1 (https=)
CN (5) CN117736178B (https=)
AR (2) AR111271A1 (https=)
AU (3) AU2018236161B9 (https=)
CA (2) CA3299704A1 (https=)
CL (1) CL2019002583A1 (https=)
CO (1) CO2019009932A2 (https=)
DK (1) DK3595665T3 (https=)
EA (1) EA201991898A1 (https=)
EC (1) ECSP19066721A (https=)
ES (1) ES2994239T3 (https=)
FI (1) FI3595665T3 (https=)
HR (1) HRP20241558T1 (https=)
HU (1) HUE069115T2 (https=)
IL (3) IL301334B2 (https=)
LT (1) LT3595665T (https=)
MX (1) MX2022006862A (https=)
NZ (4) NZ796461A (https=)
PL (1) PL3595665T3 (https=)
PT (1) PT3595665T (https=)
RS (1) RS66192B1 (https=)
SA (2) SA519410101B1 (https=)
SG (1) SG11201908159QA (https=)
SI (1) SI3595665T1 (https=)
SM (1) SMT202400468T1 (https=)
TW (2) TWI797111B (https=)
WO (1) WO2018169880A1 (https=)
ZA (1) ZA201905934B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9487495B2 (en) 2012-01-06 2016-11-08 The Scripts Research Institute Carbamate compounds and of making and using same
JOP20190107A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
EP4335848A3 (en) * 2017-03-13 2024-06-19 Lundbeck La Jolla Research Center, Inc. Dual magl and faah inhibitors
AU2019337623B2 (en) * 2018-09-13 2024-12-05 Celgene Corporation Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) piperazine-1- carboxylate, compositions and methods of use thereof
WO2020104494A1 (en) 2018-11-22 2020-05-28 F. Hoffmann-La Roche Ag New heterocyclic compounds
CA3242372A1 (en) 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)
JP2023158387A (ja) * 2022-04-18 2023-10-30 株式会社三洋物産 遊技機
JP2023158388A (ja) * 2022-04-18 2023-10-30 株式会社三洋物産 遊技機
JP2023158385A (ja) * 2022-04-18 2023-10-30 株式会社三洋物産 遊技機

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004111004A1 (en) * 2003-06-12 2004-12-23 Novo Nordisk A/S Substituted piperazine carbamates for use as inhibitors of hormone sensitive lipase
CA2525207A1 (en) * 2003-06-12 2004-12-23 Novo Nordisk A/S Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
JP2006088075A (ja) * 2004-09-27 2006-04-06 Kubota Corp 脱臭装置
TWI385164B (zh) 2005-02-17 2013-02-11 Astellas Pharma Inc Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivatives (II)
US7915251B2 (en) * 2005-03-18 2011-03-29 Institute For Chemical Genomics Alpha-helix mimetics and methods relating to the treatment of fibrosis
WO2010056309A2 (en) 2008-11-14 2010-05-20 The Scripps Research Institute Methods and compositions related to targeting monoacylglycerol lipase
US8461159B2 (en) * 2008-11-25 2013-06-11 Jannsen Pharmaceutica BV Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
FR2941696B1 (fr) 2009-02-05 2011-04-15 Sanofi Aventis Derives d'azaspiranyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
FR2945531A1 (fr) 2009-05-12 2010-11-19 Sanofi Aventis Derives de 7-aza-spiro°3,5!nonane-7-carboxylates, leur preparation et leur application en therapeutique
US20120083476A1 (en) * 2009-06-05 2012-04-05 Janssen Pharmaceutica Nv Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
RU2012136624A (ru) * 2010-01-28 2014-03-10 Мерк Шарп Энд Домэ Корп. Фармацевтические композиции для лечения боли и других показаний
TW201206440A (en) 2010-04-28 2012-02-16 Astellas Pharma Inc Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
JP2013147430A (ja) * 2010-04-28 2013-08-01 Astellas Pharma Inc 夜間頻尿の予防又は治療剤
US9487495B2 (en) 2012-01-06 2016-11-08 The Scripts Research Institute Carbamate compounds and of making and using same
PL2922845T3 (pl) 2012-11-20 2018-11-30 Merial, Inc. Związki przeciwrobacze oraz ich kompozycje i sposób stosowania
CN105263910A (zh) 2013-02-18 2016-01-20 斯克利普斯研究所 具有治疗潜力的血管加压素受体调节剂
CA2917050A1 (en) 2013-07-03 2015-01-08 Todd K. Jones Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof
EP3099332A4 (en) * 2014-01-29 2017-06-21 Madrigal Pharmaceuticals, Inc. Targeted therapeutics
WO2016014975A2 (en) * 2014-07-25 2016-01-28 Northeastern University Urea/carbamates faah magl or dual faah/magl inhibitors and uses thereof
ES2878041T3 (es) * 2015-03-18 2021-11-18 H Lundbeck As Carbamatos de piperazina y métodos para prepararlos y usarlos
UA121775C2 (uk) 2015-07-31 2020-07-27 Пфайзер Інк. 1,1,1-трифтор-3-гідроксипропан-2-ілкарбаматні похідні та 1,1,1-трифтор-4-гідроксибутан-2-ілкарбаматні похідні як інгібітори magl
WO2017197192A1 (en) 2016-05-12 2017-11-16 Abide Therapeutics, Inc. Spirocycle compounds and methods of making and using same
HU231058B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt. Gyógyászatilag hatékony aliciklusos-szubsztituált pirazolo[1,5-a]pirimidin származékok
EP4335848A3 (en) 2017-03-13 2024-06-19 Lundbeck La Jolla Research Center, Inc. Dual magl and faah inhibitors

Similar Documents

Publication Publication Date Title
JP2022068197A5 (https=)
JP2021519592A5 (https=)
JP2021518134A5 (https=)
JP2021518135A5 (https=)
JP2009523455A5 (https=)
JP2021523610A5 (https=)
JPWO2022202973A5 (https=)
JP2018168171A5 (https=)
JP2008012590A5 (https=)
JP2015532666A5 (https=)
JP2020175021A5 (https=)
JP2021525273A5 (https=)
JP2021528391A5 (https=)
JP2021512134A5 (https=)
JP2022522550A5 (https=)
JP2022144517A5 (https=)
JP2020049413A5 (https=)
JP2020180208A5 (https=)
JP2022540681A5 (https=)
JP2004529205A5 (https=)
JP2019218238A5 (https=)
JP2019073673A5 (https=)
JPWO2021152968A5 (https=)
JP2020147467A5 (https=)
JP2020135963A5 (https=)